Tuesday, 27 January 2015

A new study links XRCC2 mutations to cisplatin resistance in testicular cancer

A major research study has uncovered several new genetic mutations that could drive testicular cancer and also identified a gene which may contribute to tumours becoming resistant to platinum chemotherapy. The study is the first to use whole-exome sequencing technology to explore in detail testicular germ cell tumours, which make up the vast majority of testicular cancers and are the most common cancers in young men. Read more here.

No comments:

Post a Comment